A polygenic risk score (PRS) based on genes associated with endothelial cell function identifies patients at a higher risk of coronary artery disease, according to a new study. The risk score, which ...
Empagliflozin reduced proinflammatory cytokines and oxidative stress markers in INOCA patients with CMD, improving vascular health. Treatment led to favorable shifts in endothelial extracellular ...
It would be a rare case it heart disease would just appear out of the blue. It takes years to build before the first chest pain or abnormal test. One of the earliest shifts happens in a place most ...
Emmecell receives FDA RMAT designation for EO2002, advancing development of its regenerative cell therapy for corneal ...
Sepsis, a life-threatening systemic inflammatory response triggered by infection, has long challenged clinicians with its persistently high mortality (up to 40-50% in septic shock). At the heart of ...
The FDA granted regenerative medicine advanced therapy designation to EO2002 for the treatment of corneal edema secondary to ...
A new study uncovers how diabetic red blood cells release toxic packages that damage blood vessels, revealing a promising path for preventing serious complications. EVs derived from RBCs of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results